文献速递肺外科心外重症与机械循环支持

复合分配评分时代离体肺灌注与更长转运距离及缺血时间的全国分析

Longer travel distances and ischemic times with ex vivo lung perfusion in the Composite Allocation Score era: A nationwide analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-05-03

本研究基于OPTN数据分析了2023年3月至2025年6月间6547例肺移植,其中582例(9%)使用离体肺灌注(EVLP)。EVLP组转运距离和缺血时间更长,术后ECMO和72小时通气支持率更高、住院时间更长,但30、90、180天移植物和患者生存与未使用EVLP组相当。

要点

  • CAS实施后EVLP使用与更长转运距离和缺血时间相关
  • EVLP组术后ECMO和72小时通气支持率更高、住院时间更长
  • EVLP组与未使用EVLP组30、90、180天生存率相似

核心结论

  • CAS系统实施后,使用EVLP保存供肺的肺移植与更长转运距离和缺血时间相关,但30、90、180天移植物和患者生存与未使用EVLP者相当。

研究设计与样本

  • 研究使用OPTN数据集识别2023年3月8日至2025年6月30日期间接受肺移植的患者,比较使用与未使用EVLP的肺移植基线特征、院内结局及30、90、180天移植物和患者生存。
  • 生存分析使用Cox比例风险模型校正20项受者和供者特征。

主要发现

  • 6547例肺移植中582例(9%)使用EVLP,涉及70个肺移植中心中的36个(51%)。
  • EVLP组转运距离更长(P < .001),中位缺血时间更长(P < .001)。
  • EVLP组术后ECMO使用率更高(P < .001),72小时通气支持率更高(P = .005),中位住院时间更长(P < .001)。
  • 未校正和校正后30天死亡率EVLP组与无EVLP组分别为1.62% vs 2.1%(P = .42),90天为4.05% vs 4.59%(P = .52),180天为6.93% vs 7.25%(P = .71)。

临床怎么用

  • 在CAS分配系统下,EVLP可用于转运距离较长、缺血时间较长的供肺,尽管术后ECMO和通气支持需求及住院时间可能增加,但短期生存与常规保存相当。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Ex vivo lung perfusion (EVLP) has emerged as a safe and effective method to preserve and assess donor lungs. This study assesses nationwide trends and outcomes of EVLP use after implementation of the Composite Allocation Score (CAS) in 2023. METHODS: The Organ Procurement and Transplantation Network (OPTN) dataset was used to identify patients who received a lung transplant (LTx) between March 8, 2023, and June 30, 2025. Baseline characteristics, in-hospital outcomes, and 30-, 90- and 180-day graft and patient survival were compared in LTxs performed with and without the use of EVLP. Survival was adjusted for 20 recipient and donor characteristics using a Cox proportional hazards model. RESULTS: EVLP was used in 582 of 6547 (9%) Tx cases by 36 of 70 (51%) LTx centers. EVLP cases had a longer travel distance (P < .001) and longer median ischemic time (P < .001). EVLP was associated with higher rates of postoperative extracorporeal membrane oxygenation (ECMO; P < .001) and ventilatory support at 72 hours (P = .005) and longer median length of hospital stay (P < .001). Unadjusted and adjusted mortality was similar in the EVLP and no-EVLP groups at 30 days (1.62% vs 2.1%; P = .42), 90 days (4.05% vs 4.59%; P = .52), and 180 days (6.93% vs 7.25%; P = .71). CONCLUSIONS: Since implementation of the CAS system, EVLP has been associated with longer travel distances and ischemic times. Despite higher rates of post-LTx ECMO and ventilatory support and longer length of stay, LTx using EVLP-preserved donor lungs has comparable graft and patient survival at 30, 90 and 180 days to no-EVLP LTx.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Potel KN, Myers C, Nguyen SH, et al. Longer travel distances and ischemic times with ex vivo lung perfusion in the Composite Allocation Score era: A nationwide analysis. J Thorac Cardiovasc Surg. 2026. PMID: 42086165. doi:10.1016/j.jtcvs.2026.04.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。